For example, SCS was performed on patients with non-small cell lung cancer (NSCLC), which identified 12 key genes including MS4A1, CCL5, and GZMB as potential diagnostic and prognostic biomarkers (Sultana et al., 2023). The gene discussed is CCL5; the disease is non-small cell lung carcinoma.